Motilal Oswal Alternates invested $72M in Sensa Core, an Indian medical device company. Sensa Core will use the funds to boost product development and expand globally in the IVD segment. The investment aims to reduce India’s reliance on medical device imports and support indigenous manufacturing and exports.
Trending
- Acko Taps Top Banks for H1 2027 IPO Target
- Fairdeal.Market Secures US$15M to Scale B2B Quick Commerce Across India
- India’s Startup IPO Surge: 48+ Listings Set to Unlock INR 50,000 Cr in 2026
- Indian Startup IPO Surge Expected by 2026 Amid Market Reset
- IIT Madras Director Unfazed by India’s AI Sovereignty Concerns
- Flipkart Bolsters Leadership with Key VP Appointments
- IEA Warns Current Oil Crisis Exceeds Past Shocks
- HomeEssentials Secures $7.7M to Fuel Retail Expansion


